A detailed history of High Point Advisor Group LLC transactions in Insmed Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 3,264 shares of INSM stock, worth $230,699. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,264
Previous 3,596 9.23%
Holding current value
$230,699
Previous $248,000 0.4%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

SELL
$65.25 - $83.83 $21,663 - $27,831
-332 Reduced 9.23%
3,264 $249,000
Q4 2024

Feb 12, 2025

BUY
$66.29 - $76.63 $238,378 - $275,561
3,596 New
3,596 $248,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.58B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.